StockData
Privia Health Group, Inc. logo

Privia Health Group, Inc. (PRVA) stock

PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3081% above fair value
$24.99−0.27 (-1.07%)

Close on Nov 17, 2026Market cap $3.19BP/E 119.0Yield –

Privia Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Privia Health's revenue for the twelve months ending Jun 30, 2026 was $2.36B, up 24.1% year over year. For fiscal 2025 it was $2.12B, up 22.3% from the year before. The highest annual figure on record is $2.12B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.12B+22.3%
FY2024Dec 31, 2024$1.74B+4.7%
FY2023Dec 31, 2023$1.66B+22.2%
FY2022Dec 31, 2022$1.36B+40.4%
FY2021Dec 31, 2021$966.22M+18.3%
FY2020Dec 31, 2020$817.08M+3.9%
FY2019Dec 31, 2019$786.36M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$632.63M+21.4%
Q1 FY2026Mar 31, 2026$603.85M+25.8%
Q4 FY2025Dec 31, 2025$541.17M+17.4%
Q3 FY2025Sep 30, 2025$580.42M+32.5%
Q2 FY2025Jun 30, 2025$521.15M+23.4%
Q1 FY2025Mar 31, 2025$480.10M+15.6%
Q4 FY2024Dec 31, 2024$460.90M+4.6%
Q3 FY2024Sep 30, 2024$437.92M+4.9%
Q2 FY2024Jun 30, 2024$422.33M+2.2%
Q1 FY2024Mar 31, 2024$415.24M+7.5%
Q4 FY2023Dec 31, 2023$440.83M+21.0%
Q3 FY2023Sep 30, 2023$417.28M+21.7%
Q2 FY2023Jun 30, 2023$413.35M+23.2%
Q1 FY2023Mar 31, 2023$386.28M+23.1%
Q4 FY2022Dec 31, 2022$364.42M+32.4%
Q3 FY2022Sep 30, 2022$342.90M+36.3%
Q2 FY2022Jun 30, 2022$335.54M+48.6%
Q1 FY2022Mar 31, 2022$313.80M+46.9%
Q4 FY2021Dec 31, 2021$275.33M+28.8%
Q3 FY2021Sep 30, 2021$251.52M+21.4%
Q2 FY2021Jun 30, 2021$225.76M+23.2%
Q1 FY2021Mar 31, 2021$213.61M+0.3%
Q4 FY2020Dec 31, 2020$213.70M–
Q3 FY2020Sep 30, 2020$207.17M–
Q2 FY2020Jun 30, 2020$183.26M–
Q1 FY2020Mar 31, 2020$212.94M–

More Privia Health figures

See a number that looks wrong?